ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents

被引：87

作者：

Couper, Jennifer J. ^{[1
,2
]}

Haller, Michael J. ^{[3
]}

Greenbaum, Carla J. ^{[4
]}

Ziegler, Anette-Gabriele ^{[5
,6
]}

Wherrett, Diane K. ^{[7
]}

Knip, Mikael ^{[8
]}

Craig, Maria E. ^{[9
,10
,11
]}

机构：

[1] Womens & Childrens Hosp, Dept Diabet & Endocrinol, Adelaide, SA, Australia

[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia

[3] Univ Florida, Dept Pediat, Div Endocrinol, Gainesville, FL USA

[4] Benaroya Res Inst, Seattle, WA USA

[5] Tech Univ Munich, Klinikum Rechts Isar, Helmholtz Zentrum Munchen, Inst Diabet Res, Munich, Germany

[6] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Munich, Germany

[7] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol, Toronto, ON, Canada

[8] Univ Helsinki, Childrens Hosp, Helsinki, Finland

[9] Childrens Hosp Westmead, Dept Diabet & Endocrinol, Sydney, NSW, Australia

[10] Univ Sydney, Discipline Pediat & Child Hlth, Sydney, NSW, Australia

[11] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia

来源：

PEDIATRIC DIABETES | 2018年 / 19卷

关键词：

BETA-CELL FUNCTION; HYDROLYZED INFANT FORMULA; C-PEPTIDE; HIGH-RISK; COMBINATION THERAPY; ISLET AUTOIMMUNITY; PARTIAL REMISSION; GENETIC RISK; DOUBLE-BLIND; IMMUNE-RESPONSES;

D O I：

10.1111/pedi.12734

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：20 / 27

页数：8

共 103 条

[51] Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials [J].

Moran, Antoinette ;

Bundy, Brian ;

Becker, Dorothy J. ;

DiMeglio, Linda A. ;

Gitelman, Stephen E. ;

Goland, Robin ;

Greenbaum, Carla J. ;

Herold, Kevan C. ;

Marks, Jennifer B. ;

Raskin, Philip ;

Sanda, Srinath ;

Schatz, Desmond ;

Wherrett, Diane K. ;

Wilson, Darrell M. ;

Krischer, Jeffrey P. ;

Skyler, Jay S. ;

Pickersgill, Linda ;

de Koning, Eelco ;

Ziegler, Anette-G ;

Boeehm, Bernhard ;

Badenhoop, Klaus ;

Schloot, Nanette ;

Bak, Jens Friis ;

Pozzilli, Paolo ;

Mauricio, Didac ;

Donath, Marc Y. ;

Castano, Luis ;

Waegner, Ana ;

Lervang, Hans Henrik ;

Perrild, Hans ;

Mandrup-Poulsen, Thomas .

LANCET, 2013, 381 (9881) :1905-1915

[52] New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes [J].

Mortensen, Henrik B. ;

Hougaard, Philip ;

Swift, Peter ;

Hansen, Lars ;

Holl, Reinhard W. ;

Hoey, Hilary ;

Bjoerndalen, Hilde ;

de Beaufort, Carine ;

Chiarelli, Francesco ;

Danne, Thomas ;

Schoenle, Eugen J. ;

Aman, Jan .

DIABETES CARE, 2009, 32 (08) :1384-1390

[53] Emerging Effects of Early Environmental Factors over Genetic Background for Type 1 Diabetes Susceptibility: Evidence from a Nationwide Italian Twin Study [J].

Nistico, Lorenza ;

Iafusco, Dario ;

Galderisi, Alfonso ;

Fagnani, Corrado ;

Cotichini, Rodolfo ;

Toccaceli, Virgilia ;

Stazi, Maria Antonietta .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08) :E1483-E1491

[54]

Noble JA, 1996, AM J HUM GENET, V59, P1134

[55] Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes [J].

Norris, Jill M. ;

Yin, Xiang ;

Lamb, Molly M. ;

Barriga, Katherine ;

Seifert, Jennifer ;

Hoffman, Michelle ;

Orton, Heather D. ;

Báron, Anna E. ;

Clare-Salzler, Michael ;

Chase, H. Peter ;

Szabo, Nancy J. ;

Erlich, Henry ;

Eisenbarth, George S. ;

Rewers, Marian .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (12) :1420-1428

[56] Timing of initial cereal exposure in infancy and risk of islet autoimmunity [J].

Norris, JM ;

Barriga, K ;

Klingensmith, G ;

Hoffman, M ;

Eisenbarth, GS ;

Erlich, HA ;

Rewers, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1713-1720

[57] A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults [J].

Oram, Richard A. ;

Patel, Kashyap ;

Hill, Anita ;

Shields, Beverley ;

McDonald, Timothy J. ;

Jones, Angus ;

Hattersley, Andrew T. ;

Weedon, Michael N. .

DIABETES CARE, 2016, 39 (03) :337-344

[58] The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells [J].

Oram, Richard A. ;

Jones, Angus G. ;

Besser, Rachel E. J. ;

Knight, Bridget A. ;

Shields, Beverley M. ;

Brown, Richard J. ;

Hattersley, Andrew T. ;

McDonald, Timothy J. .

DIABETOLOGIA, 2014, 57 (01) :187-191

[59] Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment [J].

Orban, Tihamer ;

Bundy, Brian ;

Becker, Dorothy J. ;

DiMeglio, Linda A. ;

Gitelman, Stephen E. ;

Goland, Robin ;

Gottlieb, Peter A. ;

Greenbaum, Carla J. ;

Marks, Jennifer B. ;

Monzavi, Roshanak ;

Moran, Antoinette ;

Peakman, Mark ;

Raskin, Philip ;

Russell, William E. ;

Schatz, Desmond ;

Wherrett, Diane K. ;

Wilson, Darrell M. ;

Krischer, Jeffrey P. ;

Skyler, Jay S. .

DIABETES CARE, 2014, 37 (04) :1069-1075

[60] Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial [J].

Orban, Tihamer ;

Bundy, Brian ;

Becker, Dorothy J. ;

DiMeglio, Linda A. ;

Gitelman, Stephen E. ;

Goland, Robin ;

Gottlieb, Peter A. ;

Greenbaum, Carla J. ;

Marks, Jennifer B. ;

Monzavi, Roshanak ;

Moran, Antoinette ;

Raskin, Philip ;

Rodriguez, Henry ;

Russell, William E. ;

Schatz, Desmond ;

Wherrett, Diane ;

Wilson, Darrell M. ;

Krischer, Jeffrey P. ;

Skyler, Jay S. .

LANCET, 2011, 378 (9789) :412-419

← 1 2 3 4 5 6 7 8 9 10 →